1. Home
  2. STOK vs TILE Comparison

STOK vs TILE Comparison

Compare STOK & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$24.97

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

TILE

Interface Inc.

HOLD

Current Price

$36.53

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
TILE
Founded
2014
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
STOK
TILE
Price
$24.97
$36.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
3
Target Price
★ $46.46
$45.25
AVG Volume (30 Days)
★ 782.2K
389.6K
Earning Date
10-29-2026
11-06-2026
Dividend Yield
N/A
★ 0.33%
EPS Growth
★ 92.73
32.43
EPS
N/A
★ 1.28
Revenue
$184,420,000.00
★ $1,386,854,000.00
Revenue This Year
N/A
$6.25
Revenue Next Year
$39.98
$5.57
P/E Ratio
★ N/A
$28.60
Revenue Growth
★ 404.50
5.41
52 Week Low
$20.32
$24.40
52 Week High
$40.22
$40.50

Technical Indicators

Market Signals
Indicator
STOK
TILE
Relative Strength Index (RSI) 45.36 58.69
Support Level $24.21 $33.77
Resistance Level $33.61 $36.66
Average True Range (ATR) 1.33 0.92
MACD 0.35 0.17
Stochastic Oscillator 56.19 86.63

Price Performance

Historical Comparison
STOK
TILE

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).

Share on Social Networks: